Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity

Cell

Volumn 166, Issue 1, 2016, Pages 88-101

  Sisirak, Vanja ^a   Sally, Benjamin ^a,b   D'Agati, Vivette ^b   Martinez Ortiz, Wilnelly ^a   Özçakar, Z  Birsin ^c   David, Joseph ^a   Rashidfarrokhi, Ali ^a   Yeste, Ada ^d   Panea, Casandra ^b   Chida, Asiya Seema ^e   Bogunovic, Milena ^f   Ivanov, Ivaylo I ^b   Quintana, Francisco J ^d   Sanz, Inaki ^e   Elkon, Keith B ^g   Tekin, Mustafa ^h   Yalçınkaya, Fatoş ^c   Cardozo, Timothy J ^a   Clancy, Robert M ^a   Buyon, Jill P ^a   Reizis, Boris ^a,b   more..

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^c ANKARA UNIVERSITY   (Turkey)

^d HARVARD MEDICAL SCHOOL   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; AUTOANTIBODY; CHROMATIN; DNA; DNASE1L3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CHROMATIN; CONTROLLED STUDY; DENDRITIC CELL; MACROPHAGE; MOUSE; NEPHRITIS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; 129 MOUSE; ANIMAL; C57BL MOUSE; CHEMISTRY; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; KNOCKOUT MOUSE; MEMBRANE MICROPARTICLE; METABOLISM;

ANIMALS; AUTOANTIBODIES; CELL-DERIVED MICROPARTICLES; CHROMATIN; DISEASE MODELS, ANIMAL; DNA; ENDODEOXYRIBONUCLEASES; HUMANS; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84976583862     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.05.034     Document Type: Article

References (45)

1. Ahn, J., Gutman, D., Saijo, S., Barber, G.N., STING manifests self DNA-dependent inflammatory disease. Proc. Natl. Acad. Sci. USA 109 (2012), 19386–19391.
2. Al-Mayouf, S.M., Sunker, A., Abdwani, R., Abrawi, S.A., Almurshedi, F., Alhashmi, N., Al Sonbul, A., Sewairi, W., Qari, A., Abdallah, E., et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 43 (2011), 1186–1188.
3. Baron, W.F., Pan, C.Q., Spencer, S.A., Ryan, A.M., Lazarus, R.A., Baker, K.P., Cloning and characterization of an actin-resistant DNase I-like endonuclease secreted by macrophages. Gene 215 (1998), 291–301.
4. Caielli, S., Athale, S., Domic, B., Murat, E., Chandra, M., Banchereau, R., Baisch, J., Phelps, K., Clayton, S., Gong, M., et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213 (2016), 697–713.
5. Casciola-Rosen, L.A., Anhalt, G., Rosen, A., Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179 (1994), 1317–1330.
6. Choi, J., Kim, S.T., Craft, J., The pathogenesis of systemic lupus erythematosus-an update. Curr. Opin. Immunol. 24 (2012), 651–657.
7. Crow, Y.J., Type I interferonopathies: mendelian type I interferon up-regulation. Curr. Opin. Immunol. 32 (2015), 7–12.
8. Dieker, J., Tel, J., Pieterse, E., Thielen, A., Rother, N., Bakker, M., Fransen, J., Dijkman, H.B., Berden, J.H., de Vries, J.M., et al. Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis. Arthritis Rheumatol. 68 (2016), 462–472.
9. Ehlers, M., Fukuyama, H., McGaha, T.L., Aderem, A., Ravetch, J.V., TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203 (2006), 553–561.
10. Gall, A., Treuting, P., Elkon, K.B., Loo, Y.M., Gale, M. Jr., Barber, G.N., Stetson, D.B., Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36 (2012), 120–131.
11. Ganguly, D., Haak, S., Sisirak, V., Reizis, B., The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13 (2013), 566–577.
12. Ghodke-Puranik, Y., Niewold, T.B., Immunogenetics of systemic lupus erythematosus: A comprehensive review. J. Autoimmun. 64 (2015), 125–136.
13. Heidari, Y., Bygrave, A.E., Rigby, R.J., Rose, K.L., Walport, M.J., Cook, H.T., Vyse, T.J., Botto, M., Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun. 7 (2006), 592–599.
14. Holdenrieder, S., Stieber, P., Chan, L.Y., Geiger, S., Kremer, A., Nagel, D., Lo, Y.M., Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. Clin. Chem. 51 (2005), 1544–1546.
15. Jenks, S.A., Palmer, E.M., Marin, E.Y., Hartson, L., Chida, A.S., Richardson, C., Sanz, I., 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus. Arthritis Rheum. 65 (2013), 3165–3175.
16. Lavin, Y., Mortha, A., Rahman, A., Merad, M., Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 15 (2015), 731–744.
17. Lood, C., Blanco, L.P., Purmalek, M.M., Carmona-Rivera, C., De Ravin, S.S., Smith, C.K., Malech, H.L., Ledbetter, J.A., Elkon, K.B., Kaplan, M.J., Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22 (2016), 146–153.
18. Martin, J.E., Assassi, S., Diaz-Gallo, L.M., Broen, J.C., Simeon, C.P., Castellvi, I., Vicente-Rabaneda, E., Fonollosa, V., Ortego-Centeno, N., González-Gay, M.A., et al. Spanish Scleroderma Group SLEGEN consortium U.S. Scleroderma GWAS group, BIOLUPUS. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum. Mol. Genet. 22 (2013), 4021–4029.
19. Mathian, A., Weinberg, A., Gallegos, M., Banchereau, J., Koutouzov, S., IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J. Immunol. 174 (2005), 2499–2506.
20. Mayes, M.D., Bossini-Castillo, L., Gorlova, O., Martin, J.E., Zhou, X., Chen, W.V., Assassi, S., Ying, J., Tan, F.K., Arnett, F.C., et al., Spanish Scleroderma Group. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am. J. Hum. Genet. 94 (2014), 47–61.
21. Mizuta, R., Araki, S., Furukawa, M., Furukawa, Y., Ebara, S., Shiokawa, D., Hayashi, K., Tanuma, S., Kitamura, D., DNase γ is the effector endonuclease for internucleosomal DNA fragmentation in necrosis. PLoS ONE, 8, 2013, e80223.
22. Nagata, S., Kawane, K., Autoinflammation by endogenous DNA. Adv. Immunol. 110 (2011), 139–161.
23. Napirei, M., Wulf, S., Eulitz, D., Mannherz, H.G., Kloeckl, T., Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3). Biochem. J. 389 (2005), 355–364.
24. Napirei, M., Ludwig, S., Mezrhab, J., Klöckl, T., Mannherz, H.G., Murine serum nucleases–contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 276 (2009), 1059–1073.
25. Nielsen, C.T., Østergaard, O., Johnsen, C., Jacobsen, S., Heegaard, N.H., Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum. 63 (2011), 3067–3077.
26. Nielsen, C.T., Østergaard, O., Stener, L., Iversen, L.V., Truedsson, L., Gullstrand, B., Jacobsen, S., Heegaard, N.H., Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum. 64 (2012), 1227–1236.
27. Ozçakar, Z.B., Foster, J. 2nd, Diaz-Horta, O., Kasapcopur, O., Fan, Y.S., Yalçınkaya, F., Tekin, M., DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum. 65 (2013), 2183–2189.
28. Picard, C., Mathieu, A.L., Hasan, U., Henry, T., Jamilloux, Y., Walzer, T., Belot, A., Inherited anomalies of innate immune receptors in pediatric-onset inflammatory diseases. Autoimmun. Rev. 14 (2015), 1147–1153.
29. Pisetsky, D.S., Anti-DNA antibodies - quintessential biomarkers of SLE. Nat. Rev. Rheumatol. 12 (2016), 102–110.
30. Pisetsky, D.S., Gauley, J., Ullal, A.J., Microparticles as a source of extracellular DNA. Immunol. Res. 49 (2011), 227–234.
31. Radic, M., Marion, T., Monestier, M., Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 172 (2004), 6692–6700.
32. Rekvig, O.P., van der Vlag, J., Seredkina, N., Review: antinucleosome antibodies: a critical reflection on their specificities and diagnostic impact. Arthritis Rheumatol. 66 (2014), 1061–1069.
33. Richardson, C., Chida, A.S., Adlowitz, D., Silver, L., Fox, E., Jenks, S.A., Palmer, E., Wang, Y., Heimburg-Molinaro, J., Li, Q.Z., et al. Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J. Immunol. 191 (2013), 4926–4939.
34. Santiago-Raber, M.L., Amano, H., Amano, E., Baudino, L., Otani, M., Lin, Q., Nimmerjahn, F., Verbeek, J.S., Ravetch, J.V., Takasaki, Y., et al. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum. 60 (2009), 2408–2417.
35. Sharma, S., Campbell, A.M., Chan, J., Schattgen, S.A., Orlowski, G.M., Nayar, R., Huyler, A.H., Nündel, K., Mohan, C., Berg, L.J., et al. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc. Natl. Acad. Sci. USA 112 (2015), E710–E717.
36. Shlomchik, M.J., Aucoin, A.H., Pisetsky, D.S., Weigert, M.G., Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA 84 (1987), 9150–9154.
37. Snyder, M.W., Kircher, M., Hill, A.J., Daza, R.M., Shendure, J., Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 164 (2016), 57–68.
38. Sun, K., Jiang, P., Chan, K.C., Wong, J., Cheng, Y.K., Liang, R.H., Chan, W.K., Ma, E.S., Chan, S.L., Cheng, S.H., et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl. Acad. Sci. USA 112 (2015), E5503–E5512.
39. Ueki, M., Takeshita, H., Fujihara, J., Iida, R., Yuasa, I., Kato, H., Panduro, A., Nakajima, T., Kominato, Y., Yasuda, T., Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme. Clin. Chim. Acta 407 (2009), 20–24.
40. Ullal, A.J., Reich, C.F. 3rd, Clowse, M., Criscione-Schreiber, L.G., Tochacek, M., Monestier, M., Pisetsky, D.S., Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J. Autoimmun. 36 (2011), 173–180.
41. Ullal, A.J., Marion, T.N., Pisetsky, D.S., The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells. Clin. Immunol. 154 (2014), 178–187.
42. Volkman, H.E., Stetson, D.B., The enemy within: endogenous retroelements and autoimmune disease. Nat. Immunol. 15 (2014), 415–422.
43. Wardemann, H., Nussenzweig, M.C., B-cell self-tolerance in humans. Adv. Immunol. 95 (2007), 83–110.
44. Wilber, A., Lu, M., Schneider, M.C., Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection. Mol. Ther. 6 (2002), 35–42.
45. Zochling, J., Newell, F., Charlesworth, J.C., Leo, P., Stankovich, J., Cortes, A., Zhou, Y., Stevens, W., Sahhar, J., Roddy, J., et al. An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Res. Ther., 16, 2014, 438.